HALF-YEAR RESULTS 2020: UNIBAIL-RODAMCO-WESTFIELD N.V.
Amsterdam, September 25, 2020
Press Release
HALF-YEAR RESULTS 2020: UNIBAIL-RODAMCO-WESTFIELD N.V.
On September 25, 2020, Unibail-Rodamco-Westfield N.V. (“URW NV”) announced its 2020 half-year results and released its consolidated interim financial statements for the period ending June 30, 2020, which can be found on: https://www.urw-nv.com/en/investors/press-releases and as an attachment to this press release.
URW NV and its consolidated entities, together with Unibail-Rodamco-Westfield SE (“URW SE”) and its consolidated entities, form Unibail-Rodamco-Westfield (“URW”). URW SE consolidates URW NV and its controlled undertakings, and its 2020 half-year results represent a comprehensive overview of URW, and is available on: https://www.urw.com/en/investors/financial-information/financial-results
For further information, please contact:
Investor Relations Media Relations
Samuel Warwood Tiphaine Bannelier-Sudérie
Maarten Otte Tiphaine.Bannelier-Suderie@urw.com
+31 20 658 26 25
maarten.otte@urw.com
For more information, please visit: https://www.urw-nv.com/en/investors
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.About GlobeNewswire by notified
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
RESULT OF RIKSBANK CERTIFICATE SALE19.3.2024 10:15:00 CET | Press release
AuctionAuction resultsAuction date2024-03-19Start date2024-03-20Maturity date2024-03-27Interest rate4.00 %Offered volume, SEK bn956.0Total bid amount, SEK bn797.550Accepted volume, SEK bn797.550Number of bids20Percentage allotted, %100.00
Ekstraordinære indfrielser (CK93)19.3.2024 10:00:00 CET | pressemeddelelse
KommuneKredit offentliggør hermed oplysninger om ekstraordinære indfrielser (CK93) pr. 15. marts 2024. Der er pr. opgørelsesdagen ingen ekstraordinære indfrielser. For yderligere informationer om dataformat og –indhold henvises til Nasdaqs hjemmeside. Med venlig hilsen KommuneKredit
Prime Office årsregnskab 202319.3.2024 10:00:00 CET | pressemeddelelse
Selskabsmeddelelse 199/2024 19. marts 2024 PRIME OFFICE A/S: TILFREDSSTILLENDE RESULTAT I EN OMSKIFTELIG VERDEN Økonomisk rapportering pr. 31.12.2023 Resultat af primær drift på 120,7 mio. DKK mod 114,0 i 2022.Resultat før skat på 114,3 mio. DKK mod 166,2 mio. i 2022. VÆKST I BOLIGSEGMENTET – K/S Danske Immobilien Huslejer stiger med 8,5% efter alle koncernens boligejendomme samles i K/S Danske Immobilien, og 4% i stigning uden intern handel. Omsætning/huslejer andrager 111,3 mio. DKK i 2023 mod 102,6 mio. DKK i 2022Udlejningsprocent på 98,5%Investeringer og vedligeholdelse over budget VÆKST I KONTORSEGMENTET - PO KONTORSELSKABER Huslejer stiger med 6,4% Omsætning/huslejer andrager 48,0 mio. DKK i 2023 mod 45,1 mio. DKK i 2022Udlejningsprocent på 99,5% FALD I ERHVERVSSEGMENTET – MC PROPERTY FUND HAMBURG Huslejer falder med 7% efter internt frasalg af boliger til K/S Danske Immobilien Omsætning efter frasalg af ejendomme 38,0 i 2023 40,9 mio. DKK i 2022.Udlejningsprocent på 97,6%. STIGE
Leading in health technology innovation: Philips one of the top patent applicants at European Patent Office19.3.2024 10:00:00 CET | Press release
March 19, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it is one of the leading patent applicants at the European Patent Office (EPO). Building on more than 130 years of innovation, Philips’ extensive global R&D programs and collaborations position the company at the forefront of health technology innovation. In 2023, Philips improved the health and well-being of 1.9 billion people with its innovations. With 607 MedTech patent applications in 2023, Philips is the second largest applicant in EPO's Patent Index 2023 in the field of medical technology. In total, Philips contributed 1,299 patent applications across various domains, solidifying its standing among the top 10 patent filers overall. Roy Jakobs, CEO of Royal Philips, said "At Philips, our purpose is to improve people’s health and well-being through meaningful innovation. As such, we see huge opportunities to make a difference through innovatio
Annual report 202319.3.2024 09:56:49 CET | Press release
To Nasdaq OMX Copenhagen A/S Public announcement no. 553 March 19th, 2024 ANNUAL REPORT FOR GLUNZ & JENSEN HOLDING A/S FOR THE FISCAL YEAR 2023 The annual report for the fiscal year 2023 was reviewed and approved at the Board of Directors meeting today. The Board of Directors announces the following consolidated financial statements for 2023 set for approval at the Annual General Meeting on April 10th, 2024. Please observe that the 2023 figures cover a 12-month period, whereas the 2022 figures cover a 9-month period. The annual report 2023 has the following key figures: The Group realized a revenue of DKK 143,3 million (2022: DKK 103,4 million). Gross profit totalled DKK 31,9 million (2022: DKK 27,5 million), equal to a gross profit margin of 22,2% (2022: 26,6%). EBITDA was DKK 10,8 million (2022: DKK 18,2 million). Profit before tax for the year totalled DKK 3,5 million (2022: DKK 15,3 million). The result is in line with the guidance to the market. The financial statements for 2023 a